1. Re-engineering CNS drug discovery and development using computer aided modeling

   • Hugo Geerts

   Editorial 23 November 2020 Article: 7

2. Molecular docking and pharmacophoric modelling of 1,5-disubstituted tetrazoles as inhibitors of two proteins present in cancer, the ABL and the mutated T315I kinase

   • Erik Díaz-Cervantes
   • Carlos J. Cortés-García
   • Abel Suárez-Castro

   Original Research 22 November 2020 Article: 6

   

3. Hydrochlorothiazide and Indapamide bind the NADPH binding site of bacterial Dihydrofolate Reductase: results of an in-silico study and their implications

   • Sumanpreet Kaur
   • Rajasri Bhattacharyya
   • Dibyajyoti Banerjee

   Original Research 12 November 2020 Article: 5

   

4. In silico predictions on the possible mechanism of action of selected bioactive compounds against breast cancer

   • Aliyu Muhammad
   • Babangida Sanusi Katsayal
   • Zak-wan Sidi Umar

   Original Research 09 November 2020 Article: 4

   

5. Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2

   • Shravan B. Rathod
   • Pravin B. Prajapati
   • Mohmedyasin F. Mansuri

   Original Research 09 November 2020 Article: 3

   

6. Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies

   • Opeyemi Iwaloye
   • Olusola Olalekan Elekofehinti
   • Toyin Mary Fadipe

   Original Research 12 September 2020 Article: 2

   

7. Structural modification of aspirin to design a new potential cyclooxygenase (COX-2) inhibitors

   • Monir Uzzaman
   • Tareq Mahmud

   Original Research 04 March 2020 Article: 1